New scan technique could spot lung trouble early in transplant patients
NCT ID NCT05866302
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a special CT scan analysis called parametric response mapping (PRM) can detect early signs of chronic lung disease in people who have had a stem cell transplant. Researchers will follow 375 patients for one year to see if PRM patterns predict lung function decline or survival. The goal is to improve monitoring and timing of treatment for lung complications after transplant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a new way to predict lung problems early in transplant patients, helping doctors intervene sooner.
What could go wrong
This is an observational study, not testing a treatment. It may not lead to direct benefits for participants, and the imaging technique might not prove reliable in larger groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT-VERSUS-HOST-DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana Farber
NOT_YET_RECRUITINGBoston, Massachusetts, 02215, United States
Contact Email: •••••@•••••
Contact
-
Emory University
NOT_YET_RECRUITINGAtlanta, Georgia, 30322, United States
Contact Email: •••••@•••••
Contact
-
Fred Hutchinson Cancer Research Center
RECRUITINGSeattle, Washington, 98109, United States
Contact Email: •••••@•••••
Contact
-
MD Anderson
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
Contact Email: •••••@•••••
Contact
-
Stanford Hospital
RECRUITINGStanford, California, 94305, United States
Contact Email: •••••@•••••
Contact
-
The University of Michigan Cancer Center
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-••••
Contact